title: Sialolithiasis in an HIV-1-infected patient treated with atazanavir/ritonavir monotherapy.
authors.forename: Minh P
authors.initials: MP
authors.lastname: Lê
authors.forename: Hind
authors.initials: H
authors.lastname: Stitou
authors.forename: Cathia
authors.initials: C
authors.lastname: Soulie
authors.forename: Christine
authors.initials: C
authors.lastname: Katlama
authors.forename: Gilles
authors.initials: G
authors.lastname: Peytavin
mesh_terms: D000328:Adult; D019380:Anti-HIV Agents / Q000008:administration & dosage / Q000009:adverse effects*; D000069446:Atazanavir Sulfate; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D008297:Male; D009842:Oligopeptides / Q000008:administration & dosage / Q000009:adverse effects*; D011725:Pyridines / Q000008:administration & dosage / Q000009:adverse effects*; D019438:Ritonavir / Q000008:administration & dosage / Q000009:adverse effects*; D015494:Salivary Gland Calculi / Q000139:chemically induced* / Q000175:diagnosis
chemical_list: D019380:Anti-HIV Agents; D009842:Oligopeptides; D011725:Pyridines; D000069446:Atazanavir Sulfate; D019438:Ritonavir